Hodogaya Chemical Co., Ltd.

4112.T
Specialty Chemicals
2026/11/18 13:39 Updated
Market Cap: $192.7M (¥30.7B)
Stock Price: $12.10 (¥1,930)
Exchange Rate: 1 USD = ¥159.49

Notice of Revision to Full-Year Earnings Forecast

Revised upward the full-year (2026/4/1-2027/3/31) earnings forecast. Net sales increased by 2,000 million yen from the previous forecast, operating income by 1,500 million yen, ordinary income by 1,200 million yen, net income attributable to owners of parent by 300 million yen, and net income per share revised upward to 100.49 yen. The revision is driven by organic EL material sales in the functional dyes segment exceeding expectations, while prolonged Middle East tensions leading to higher raw material and fuel prices and economic slowdown uncertainty remain concerns. Dividend forecast (30 yen per share) is unchanged.

Importance:
Page Updated: November 11, 2026
IR Disclosure Date: November 11, 2026

Key Figures

  • Net Sales: 54,000 million yen
  • Operating Income: 4,900 million yen
  • Ordinary Income: 4,500 million yen

AI要約

Summary of Revision to Earnings Forecast

Hodogaya Chemical Co., Ltd. has revised its consolidated full-year earnings forecast for the fiscal year ending March 2027. Net sales are expected to be 54,000 million yen, operating income 4,900 million yen, ordinary income 4,500 million yen, net income attributable to owners of parent 1,600 million yen, and net income per share 100.49 yen. All indicators have been revised upward compared with the previous forecast. The primary reason is that sales of organic EL materials in the functional dyes segment exceeded plan. On the other hand, prolonged Middle East tensions leading to higher raw material and fuel prices and concerns about an economic slowdown cast uncertainty on future outlooks. The dividend forecast (30 yen per share) remains unchanged.

Outlook and Key Considerations

Considering the potential impact of prolonged geopolitical risks and rising raw material and fuel costs on raw material and energy expenses, we will continue to take a cautious stance. The revision also incorporates listing-related expenses for SFC CO., LTD. and delays in the timing of consolidation of Framochem as a consolidated subsidiary; these factors may affect future consolidated performance.

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Hodogaya Chemical Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →